scholarly article | Q13442814 |
P50 | author | Bodo Melnik | Q88156770 |
P2860 | cites work | Clinical efficacy of etanercept for treatment of PAPA syndrome | Q84596254 |
Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids | Q24306330 | ||
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1 | Q24315566 | ||
AMPK phosphorylation of raptor mediates a metabolic checkpoint | Q24329244 | ||
IKK beta suppression of TSC1 links inflammation and tumor angiogenesis via the mTOR pathway | Q24337225 | ||
Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor | Q24338711 | ||
Signaling by target of rapamycin proteins in cell growth control | Q24522447 | ||
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling | Q24536092 | ||
Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex | Q24559347 | ||
Updates of mTOR inhibitors | Q24607170 | ||
Spatial regulation of the mTORC1 system in amino acids sensing pathway | Q24612853 | ||
FoxOs inhibit mTORC1 and activate Akt by inducing the expression of Sestrin3 and Rictor | Q24632191 | ||
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study | Q24654138 | ||
Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling | Q24677061 | ||
TSC2 mediates cellular energy response to control cell growth and survival | Q27860970 | ||
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling | Q28131740 | ||
Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency | Q28249019 | ||
Interaction of FoxO1 and TSC2 induces insulin resistance through activation of the mammalian target of rapamycin/p70 S6K pathway | Q28271322 | ||
Botanicals in dermatology: an evidence-based review | Q28283763 | ||
The mTOR pathway and its role in human genetic diseases | Q28285976 | ||
Innovations in natural ingredients and their use in skin care | Q28287779 | ||
Which plant for which skin disease? Part 1: Atopic dermatitis, psoriasis, acne, condyloma and herpes simplex | Q28290400 | ||
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway | Q28646919 | ||
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress | Q29614493 | ||
Ras, PI(3)K and mTOR signalling controls tumour cell growth | Q29614734 | ||
Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism | Q29614737 | ||
Activation of a metabolic gene regulatory network downstream of mTOR complex 1 | Q29615179 | ||
Accelerated wound healing by mTOR activation in genetically defined mouse models. | Q30389607 | ||
mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway | Q30425628 | ||
Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis | Q33734679 | ||
Anergic T cells are metabolically anergic | Q33908515 | ||
Reactive oxygen species in tumor necrosis factor-alpha-activated primary human keratinocytes: implications for psoriasis and inflammatory skin disease | Q33915587 | ||
Acne vulgaris: a disease of Western civilization | Q33963012 | ||
IGF-1 induces SREBP-1 expression and lipogenesis in SEB-1 sebocytes via activation of the phosphoinositide 3-kinase/Akt pathway. | Q33988649 | ||
Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem | Q34002248 | ||
Diet and acne: a review of the evidence | Q34016843 | ||
Food combination and Alzheimer disease risk: a protective diet | Q34022031 | ||
Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. | Q34063643 | ||
Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle. | Q34161987 | ||
Nutrition and Alzheimer's disease: the detrimental role of a high carbohydrate diet | Q34170620 | ||
Clinical practice. Acne | Q34409492 | ||
The medicinal action of androgens and green tea epigallocatechin gallate. | Q34482571 | ||
13-cis Retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes | Q34507245 | ||
Inflammatory events are involved in acne lesion initiation | Q34535060 | ||
High school dietary dairy intake and teenage acne | Q34554810 | ||
Implications for the role of diet in acne | Q34560004 | ||
The prevalence of acne in adults 20 years and older | Q34583936 | ||
Milk consumption and acne in teenaged boys | Q34587075 | ||
Current protein intake in America: analysis of the National Health and Nutrition Examination Survey, 2003-2004. | Q34591755 | ||
Role of insulin, insulin-like growth factor-1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris | Q34611221 | ||
The two TORCs and Akt. | Q34617423 | ||
The effect of a high-protein, low glycemic-load diet versus a conventional, high glycemic-load diet on biochemical parameters associated with acne vulgaris: a randomized, investigator-masked, controlled trial | Q34621172 | ||
Mechanisms involved in the coordinate regulation of mTORC1 by insulin and amino acids | Q34624351 | ||
Nutrition and acne | Q34624872 | ||
Evidence for acne-promoting effects of milk and other insulinotropic dairy products | Q34627099 | ||
Acne and risk of prostate cancer | Q34792625 | ||
Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet | Q34942346 | ||
Milk--the promoter of chronic Western diseases | Q34949505 | ||
Over-stimulation of insulin/IGF-1 signaling by western diet may promote diseases of civilization: lessons learnt from laron syndrome | Q35121240 | ||
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function | Q35172754 | ||
Hyperinsulinemic diseases of civilization: more than just Syndrome X | Q35550817 | ||
Isotretinoin and FoxO1: A scientific hypothesis | Q35558873 | ||
PI3K/mTOR signaling regulates prostatic branching morphogenesis | Q35575601 | ||
Regulation of gluconeogenesis by Krüppel-like factor 15 | Q35843674 | ||
Ser/Thr phosphorylation of IRS proteins: a molecular basis for insulin resistance | Q36020413 | ||
Differential requirement of mTOR in postmitotic tissues and tumorigenesis | Q39889915 | ||
FoxO1 mediates PTEN suppression of androgen receptor N- and C-terminal interactions and coactivator recruitment | Q39906248 | ||
Resveratrol-containing gel for the treatment of acne vulgaris: a single-blind, vehicle-controlled, pilot study. | Q39972556 | ||
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells | Q40050621 | ||
The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor | Q40091020 | ||
Inhibition of amino acid-mTOR signaling by a leucine derivative induces G1 arrest in Jurkat cells | Q40673162 | ||
Outcomes of 3% green tea emulsion on skin sebum production in male volunteers | Q40976892 | ||
Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells | Q41427795 | ||
Growth hormone and amino acid supply interact synergistically to control insulin-like growth factor-I production and gene expression in cultured ovine hepatocytes | Q42479785 | ||
The beneficial effects of a Paleolithic diet on type 2 diabetes and other risk factors for cardiovascular disease | Q42691546 | ||
The influence of dietary patterns on acne vulgaris in Koreans | Q42914845 | ||
Short-term isotretinoin treatment decreases insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels: does isotretinoin affect growth hormone physiology? | Q43175478 | ||
Relationship between dietary intake and the development of type 2 diabetes in a Chinese population: the Hong Kong Dietary Survey. | Q43500684 | ||
High intakes of milk, but not meat, increase s-insulin and insulin resistance in 8-year-old boys | Q45172287 | ||
Amino acid signaling through the mammalian target of rapamycin (mTOR) pathway: Role of glutamine and of cell shrinkage | Q45191326 | ||
Testosterone induces cardiomyocyte hypertrophy through mammalian target of rapamycin complex 1 pathway. | Q45994009 | ||
The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. | Q46021252 | ||
The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris. | Q46052522 | ||
Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells. | Q46103793 | ||
Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk | Q46401809 | ||
Androgen induction of steroid 5 alpha-reductase may be mediated via insulin-like growth factor-I. | Q46543907 | ||
A pilot study to determine the short-term effects of a low glycemic load diet on hormonal markers of acne: a nonrandomized, parallel, controlled feeding trial | Q46581684 | ||
Green tea extract and (-)-epigallocatechin-3-gallate inhibit mast cell-stimulated type I collagen expression in keloid fibroblasts via blocking PI-3K/AkT signaling pathways | Q46690751 | ||
Metabolic fate of leucine: a significant sterol precursor in adipose tissue and muscle | Q47833187 | ||
Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. | Q50527200 | ||
Revving the engine: signal transduction fuels T cell activation. | Q50926090 | ||
Effect of insulin-like growth factor-1 deficiency or administration on the occurrence of acne. | Q51534027 | ||
Diet, serum insulin-like growth factor-I and IGF-binding protein-3 in European women. | Q51791620 | ||
All-trans-retinoic acid and 13-cis-retinoic acid: pharmacokinetics and biological activity in different cell culture models of human keratinocytes. | Q52927222 | ||
Permanent impairment of insulin resistance from pregnancy to adulthood: the primary basic risk factor of chronic Western diseases. | Q53390134 | ||
mTORC1 activity as a determinant of cancer risk--rationalizing the cancer-preventive effects of adiponectin, metformin, rapamycin, and low-protein vegan diets. | Q54566139 | ||
Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients. | Q54570063 | ||
Dihydrotestosterone stimulates amino acid uptake and the expression of LAT2 in mouse skeletal muscle fibres through an ERK1/2-dependent mechanism. | Q54587962 | ||
The role of FOXO in the regulation of metabolism. | Q54742441 | ||
Milk consumption and acne in adolescent girls. | Q55042668 | ||
A low-glycemic-load diet improves symptoms in acne vulgaris patients: a randomized controlled trial. | Q55044166 | ||
Insulin-sensitizing agents in women with polycystic ovary syndrome | Q56997818 | ||
Folliculocystic and collagen hamartoma of tuberous sclerosis complex | Q57554956 | ||
Metabolic effects of amino acid mixtures and whey protein in healthy subjects: studies using glucose-equivalent drinks | Q58448413 | ||
Cellular dynamics of comedo formation in acne vulgaris | Q68486561 | ||
Lipogenesis in isolated human sebaceous glands | Q68872412 | ||
Cutaneous lipogenesis. Major pathways of carbon flow and possible interrelationships between the epidermis and sebaceous glands | Q70044590 | ||
Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation | Q74595877 | ||
Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels | Q79241452 | ||
Resveratrol inhibition of Propionibacterium acnes | Q80195412 | ||
The effect of a low glycemic load diet on acne vulgaris and the fatty acid composition of skin surface triglycerides | Q80452434 | ||
Abnormal production of tumor necrosis factor (TNF) -- alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected] | Q81097626 | ||
[Acne vulgaris. Role of diet] | Q82672316 | ||
Milk signalling in the pathogenesis of type 2 diabetes | Q83252335 | ||
Diet and acne | Q83908753 | ||
Metformin for cancer prevention | Q84417794 | ||
Milk consumption and the prepubertal somatotropic axis | Q36176046 | ||
Interplay between FOXO, TOR, and Akt. | Q36189618 | ||
Fuel feeds function: energy metabolism and the T-cell response | Q36292868 | ||
Acne: Diet and acnegenesis | Q36349283 | ||
mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer | Q36798847 | ||
Role of AMP-activated protein kinase in the metabolic syndrome and in heart disease. | Q37005641 | ||
Protein quality assessment: impact of expanding understanding of protein and amino acid needs for optimal health | Q37158929 | ||
Amino acid regulation of TOR complex 1. | Q37162253 | ||
Infectious tolerance via the consumption of essential amino acids and mTOR signaling | Q37246191 | ||
A new player in the orchestra of cell growth: SREBP activity is regulated by mTORC1 and contributes to the regulation of cell and organ size | Q37368338 | ||
LKB1 and AMP-activated protein kinase control of mTOR signalling and growth | Q37383513 | ||
Androgen abuse in the community | Q37447948 | ||
Nutrient control of TORC1, a cell-cycle regulator | Q37472419 | ||
Resveratrol: cellular actions of a potent natural chemical that confers a diversity of health benefits | Q37520034 | ||
FoxO1 - the key for the pathogenesis and therapy of acne? | Q37691463 | ||
Metabolism in T cell activation and differentiation | Q37699927 | ||
Tuberous sclerosis complex: linking cancer to metabolism | Q37770321 | ||
The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism | Q37792556 | ||
The role of transcription factor FoxO1 in the pathogenesis of acne vulgaris and the mode of isotretinoin action | Q37798709 | ||
mTORC1 signaling: what we still don't know | Q37817590 | ||
Intracellular amino acid sensing and mTORC1-regulated growth: new ways to block an old target? | Q37820481 | ||
Acne-associated syndromes: models for better understanding of acne pathogenesis | Q37825558 | ||
mTOR Signalling in Health and Disease | Q37856364 | ||
New, relevant information and innovative interventions in the management of acne | Q37874909 | ||
Metformin as an antitumor agent in cancer prevention and treatment | Q37883608 | ||
The association of acne vulgaris with diet. | Q37931819 | ||
mTOR signaling and metabolic regulation of T cells: new potential therapeutic targets in autoimmune diseases. | Q37935848 | ||
Dexamethasone represses signaling through the mammalian target of rapamycin in muscle cells by enhancing expression of REDD1. | Q38308030 | ||
Low serum insulin in traditional Pacific Islanders--the Kitava Study | Q39181702 | ||
Resveratrol is a class IA phosphoinositide 3-kinase inhibitor | Q39253076 | ||
Resveratrol downregulates PI3K/Akt/mTOR signaling pathways in human U251 glioma cells. | Q39440979 | ||
Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression. | Q39456571 | ||
Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner | Q39707409 | ||
Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation | Q39772455 | ||
P433 | issue | 1 | |
P304 | page(s) | 20-32 | |
P577 | publication date | 2012-01-01 | |
P1433 | published in | Dermato-endocrinology | Q26842418 |
P1476 | title | Dietary intervention in acne: Attenuation of increased mTORC1 signaling promoted by Western diet | |
P478 | volume | 4 |
Q43494823 | Acne and whey protein supplementation among bodybuilders |
Q51696688 | Acne vulgaris: an inflammasomopathy of the sebaceous follicle induced by deviated FoxO1/mTORC1 signalling. |
Q37101662 | Are therapeutic effects of antiacne agents mediated by activation of FoxO1 and inhibition of mTORC1? |
Q34432553 | Botanical and phytochemical therapy of acne: a systematic review |
Q64269559 | Dairy Products: Is There an Impact on Promotion of Prostate Cancer? A Review of the Literature |
Q91865163 | Dairy consumption and acne: a case control study in Kabul, Afghanistan |
Q64094635 | Dietary Patterns Associated with Sebum Content, Skin Hydration and pH, and Their Sex-Dependent Differences in Healthy Korean Adults |
Q36643595 | Discovering the link between nutrition and skin aging |
Q91666107 | Diseases of Civilization - Cancer, Diabetes, Obesity and Acne - the Implication of Milk, IGF-1 and mTORC1 |
Q39742115 | Evaluation of anti-acne property of purified bee venom serum in humans |
Q53843026 | Insulin resistance and skin diseases. |
Q92730114 | Integrated targeted serum metabolomic profile and its association with gender, age, disease severity, and pattern identification in acne |
Q26800264 | Linking diet to acne metabolomics, inflammation, and comedogenesis: an update |
Q24594618 | Milk is not just food but most likely a genetic transfection system activating mTORC1 signaling for postnatal growth |
Q43416357 | Pathophysiology of acne. What is confirmed? |
Q37101729 | Potential role of FoxO1 and mTORC1 in the pathogenesis of Western diet-induced acne |
Q36086022 | Preliminary evidence for vitamin D deficiency in nodulocystic acne |
Q34616910 | Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females |
Q54220200 | Skin expression of mammalian target of rapamycin and forkhead box transcription factor O1, and serum insulin-like growth factor-1 in patients with acne vulgaris and their relationship with diet. |
Q26767243 | The epidemiology of acne vulgaris in late adolescence |
Q36402333 | The impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancer |
Q37531845 | The possible role of diet in the pathogenesis of adult female acne |
Q36129988 | The skin: A powerful hormone factory |
Q34980513 | Toll-like receptor 2 activation and comedogenesis: implications for the pathogenesis of acne |
Q54441597 | [Acne and diet]. |
Q41715894 | p53: key conductor of all anti-acne therapies |
Search more.